E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
TVTX holding history
Travere Therapeutics, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TVTX overviewAll 13F holders of TVTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 8,328
- Value
- $473.1K
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 8,328 | $473.1K | <0.1% | −10,834−56.5% | Reduced | Holders |
| Q1 2026 | 19,162 | $569.3K | <0.1% | – | No prior filing | Holders |
| Q3 2025 | – | – | – | – | Not filed | Holders |
| Q2 2025 | 13,789 | $204.1K | <0.1% | +236+1.7% | Added | Holders |
| Q1 2025 | 13,553 | $242.9K | <0.1% | +1,072+8.6% | Added | Holders |
| Q4 2024 | 12,481 | $217.4K | <0.1% | +12,481 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −11,071−100.0% | Sold out | Holders |
| Q2 2024 | 11,071 | $91.0K | <0.1% | −17,057−60.6% | Reduced | Holders |
| Q1 2024 | 28,128 | $216.9K | <0.1% | +5,218+22.8% | Added | Holders |
| Q4 2023 | 22,910 | $206.0K | <0.1% | +4,314+23.2% | Added | Holders |
| Q3 2023 | 18,596 | $166.0K | <0.1% | −8,198−30.6% | Reduced | Holders |
| Q2 2023 | 26,794 | $412.0K | <0.1% | +8,262+44.6% | Added | Holders |
| Q1 2023 | 18,532 | $417.0K | <0.1% | +1,781+10.6% | Added | Holders |
| Q4 2022 | 16,751 | $352.0K | <0.1% | +2,606+18.4% | Added | Holders |
| Q3 2022 | 14,145 | $349.0K | <0.1% | −809−5.4% | Reduced | Holders |
| Q2 2022 | 14,954 | $362.0K | <0.1% | +7,003+88.1% | Added | Holders |
| Q1 2022 | 7,951 | $205.0K | <0.1% | +7,951 | New | Holders |